ABSTRACT In 1983 a postal survey of the bronchoscopic practice of chest physicians in the United Kingdom produced a 90% response rate. Two hundred and thirty one physicians were carrying out bronchoscopy; they had performed about 40 000 bronchoscopies in the preceding year, 87% of these being fibreoptic procedures with topical anaesthesia. The mortality rate of fibreoptic bronchoscopy was 0.04%, with a 0.12% incidence of major complications. Transbronchial biopsy carried both an appreciably higher mortality rate of 0.12% and a major complication rate of 2.7%. There is wide variation in the use and choice of sedative drugs for fibreoptic bronchoscopy. Many of the drug combinations could be criticised on pharmacological grounds. The mean dose of lignocaine was 342 mg, most operators exceeding the usual maximum recommended dose; but adverse reactions were rare. Routine supplemental oxygen was given by only 18% of bronchoscopists. Basic resuscitation equipment was often inadequate. Radiological screening was used for transbronchial lung biopsy by 53% of respondents and significantly reduced the incidence of pneumothorax from 2.9% to 1.8%. Both the number of bronchoscopies performed and the complication rate were higher than previous estimates. Bronchoscopists should re-examine their policy on drugs and safety precautions to minimise the risks of the procedure.
Rigid bronchoscopy still has a role in the diagnosis and management of massive haemoptysis and stridor from large airways obstruction. Since its introduction in 1967 the fibreoptic bronchoscope has, however, become the instrument most widely used for routine diagnostic purposes in the United Kingdom. The principal advantages are ease of insertion without the need for general anaesthesia and an increased range of view of the bronchial tree.'
There have been two retrospective studies of the frequency and complications of fibreoptic bronchoscopy from the United States. In 1974 Credle et al reported a mortality rate of 0.01% and a major complication rate of 0.08% in 24501 bronchoscopies from 192 centres.2 In 1976 a similar survey of 48 000 procedures gave a mortality rate of 0.02% with a 0.3% incidence of major complications.3 There have Address for reprint requests: Dr FG Simpson, Leeds Chest Clinic, 74 New Briggate, Leeds LS7 4RB. Accepted 14 October 1985 been three smaller prospective studies. From the United States Pereira et al reported a mortality of 0.1% and a major complication rate of 1.7% in 908 bronchoscopies4 and Dreison et al gave figures of 0.5% and 5% respectively for 205 procedures.5 A study from the Soviet Union of 1146 fibreoptic bronchoscopies reported zero mortality and a 0.3% major complication rate, compared with rates of 0. 17% and 1. 1% respectively in 4595 examinations with the rigid bronchoscope. 6 There is little information about bronchoscopic practice in the UK. It was estimated in 19747 that 15 000 patients a year in the UK might require bronchoscopy. The studies that are available8 l are small and from single centres, and tend to concentrate on diagnostic yield rather than complications. It was concluded that there was a need for a larger scale survey of bronchoscopic practice by chest physicians in the UK, particularly to obtain data about the risks of the procedure. This paper reports the result of a postal survey of medical bronchoscopic practice in the UK in which an attempt was made to contact all physicians practising bronchoscopy.
Simpson, Arnold, Purvis, Belfield, Muers, Cooke Analysis of the apparent causes of the deaths and major complications (tables 3 and 4) showed that all four deaths and 91 of the 93 complications that followed transbronchial biopsy were due to haemorrhage or pneumothorax, while only two of 13 deaths and 10 of 44 complications after simple bronchoscopy were due to these biopsy related complications. Thirty one of the 74 pneumothoraces reported as major complications required intercostal tube drainage. Of the other complications, the most frequent was respiratory depression. There were two serious reactions to local anaesthetic. The most common cause of death after straightforward fibreoptic bronchoscopy was myocardial infarction or left ventricular failure. The death listed as "non-specific" occurred after a general anaesthetic. Six of the 17 patients who died had bronchial neoplasms, two had leukaemia (both dying of haemorrhage after transbronchial lung biopsy), and one had pulmonary tuberculosis. There were no significant associations between the incidence of death and major complications and the type of bronchoscopic practice, the numbers of bronchoscopies performed by each unit, or the type of hospital in which the procedure was performed. There was an apparently higher incidence of deaths and major complications in teaching hospitals than in district general hospitals, but this probably reflected the fact that patients in teaching hospitals were 1.64 times more likely to undergo transbronchial biopsy at the time of bronchoscopy than patients in district general hospitals.
There were no reported deaths or major complications associated with bronchoalveolar lavage or bronchography.
PREOPERATIVE ASSESSMENTS
One hundred and fifty physicians (66%) routinely performed some assessment of respiratory function (for example, FEV1, blood gas tensions) before bronchoscopy. Eighty three (37%) enforced a "nil by mouth" policy from the night before the procedure, 108 (48%) for four hours or more but not overnight, and 33 (15%) for less than four hours. The policies on fluid restriction were not influenced by the sedation used for the procedure. Routine investigations before transbronchial lung biopsy included a platelet count by 150 physicians (75%), prothrombin time or clotting screen by 129 (65%), blood grouping by 43 (22%), and cross matching of blood by 13 (6.5%).
USE OF SEDATIVE DRUGS
Of the 227 physicians performing fibreoptic bronchoscopy, 13 (6%) did so without routinely using any sedative drugs, 105 (47%) used a premedication injection of sedative given 30 minutes or more before the procedure, 39 (17%) used intravenous sedatives at the time of the procedure, 43 (19%) used both intravenous drugs and premedication, and 26 (12%) gave a general anaesthetic. The usual sedation practice of one respondent was not stated.
Further details of the sedative drugs used were provided by 187 respondents (table 5) . Of the 103 physicians using a single drug, 80 (78%) gave an opiate, 76 physicians using an intramuscular injection of morphine or papaveretum as a premedication while four used intravenous synthetic opiates such as fentanyl at the time of the procedure. Of the 22 physicians using a benzodiazepine alone, 12 gave the drug intravenously at the time of t-he procedure, three used an oral benzodiazepine as a premedication, and seven gave an intramuscular injection as a premedication. Most of those using two drugs used either an opiatebenzodiazepine combination or one of the standard neuroleptanalgesic combinations of a short acting opiate with a tranquilliser-for example, phenoperidine and droperidol. Of the 43 operators using the opiate-benzodiazepine combination, 25 gave the opiate as a premedication and one gave an intramuscular premedication injection of benzodiazepine with intravenous opiate at the time of the procedure. In all, 15 operators used benzodiazepines by intramuscular injection despite the variable absorption when they are given by this route. There was no association between overall complications and any particular sedative combination. Information relating to sedation was available for 10 of the reported episodes of life threatening respiratory depression. Seven of these occurred in units using intravenous sedatives; three occurred after premedication alone (0.2 > p > 0.1).
An anticholinergic drug was used by 174 physicians (87%), 142 (71 %) using atropine and 32 (16%) scopolamine. In 89% of cases the anticholinergic agent was given at least 30 minutes before operation by intramuscular injection.
LOCAL ANAESTHESIA Details of local anaesthetic usage were available for 214 bronchoscopists. One hundred and ninety eight (92%) used lignocaine, 15 (7%) cocaine, and 1 (0.5%) prilocaine. Three physicians added adrenaline to the local anaesthetic. The mean dose of lignocaine used has been calculated for both the midpoint and the maximum of the dosage range quoted by respondents. For the midpoint the mean dose was 342 (SD 165, (range 100-960) mg) and for the maximum of the dosage range 368 (SD 185, range 100-1180) mg. The vast majority of operators used a spray to apply local anaesthetic to the upper airway and injected local anaesthetic solution through the bronchoscope to anaesthetise the vocal cords and lower airways. Cricothyroid puncture was used by 29 bronchoscopists (15%).
OXYGEN AND POSTOPERATIVE OBSERVATIONS
Supplemental oxygen was given routinely by 18% of respondents, but 9.5% never gave oxygen. Fifty three (27%) of operators maintained intravenous access with an indwelling needle or cannula during bronchoscopy. Eating and drinking were prohibited for over four hours after bronchoscopy by 17 
Discussion
A postal questionnaire survey has two important drawbacks. Firstly, some less successful bronchoscopists may not have replied and, secondly, for some of the data the survey relies on the memory of participants and some respondents may have been reluctant to recall and record deaths or major complications. Both factors would lead to an underestimate of the complication rate of the procedure. This may in part account for the lower rates of death and complications reported in surveys of this type2 3 than in some prospective surveys.45 The low rates of mortality and morbidity in the published prospective studies are, however, based on small numbers of procedures and this may account for the apparent difference in mortality rates. 46 Questionnaire surveys can obtain information on large numbers of procedures easily. The 90% response rate in this study, which compares favour- (8.5) Postal survey of bronchoscopic practice by physicians in the United Kingdom ably with the 77% and 31% of previous studies,2 3 and the care with which the lengthy questionnaire was completed by respondents make us feel that the information is likely to be accurate. Postal surveys have the advantage of reflecting nationwide practice rather than results from selected centres. A major finding of the survey was the much greater number of medical bronchoscopies being performed than was estimated 10 years ago (around 40 000, compared with an estimated 15 000 in 1974). The death and major complication rates associated with this large number of bronchoscopies are low, but appreciably higher than were found in the mid 1970s in comparable surveys in the United States. Taken together these observations raised the possibility that bronchoscopies are being performed now on patients who on account of age or general condition may have been considered unfit for the procedures in the past.
A further explanation for a higher overall complication rate than in the 1970s is the greater frequency with which transbronchial lung biopsy is being performed. Previous British studies of small numbers of transbronchial biopsies12 13 have reported no fatalities. Our figures show a significantly greater risk of death and of major complications with transbronchial biopsy than with straightforward fibreoptic bronchoscopy and the mortality rate is similar to that found in an American survey covering over 5000 procedures. '4 In this survey the definition of a major complication was left to the judgement of the clinician concerned whereas earlier studies attempted stricter definitions, making comparison of the rate of complications between different surveys difficult. Comparison between complication rates of bronchoscopy with and without transbronchial biopsy within a survey is probable valid and the 20 fold increase in major complications seen with transbronchial biopsy is highly significant. Furthermore, the range of complications after transbronchial biopsy differs from that reported with simple bronchoscopy.
Little information is available about the most appropriate sedation for fibreoptic bronchoscopy despite the observation that respiratory depression associated with use of sedatives is one of the more common complications of the procedure.2 Although some authorities maintain that benzodiazepines are inadequate and recommend opiates,'5 16 Rees et al, ' 7 in a controlled double blind trial, found no differences between intramuscular papaveretum, diazepam, and atropine alone but did show that intravenous diazepam was preferred to placebo by patients. Dorward et al'8 found that bronchoscopists (but not patients) preferred papaveretum to temazepam on the grounds of increased cooperation, but noted that this was achieved at the cost of significant respiratory depression as assessed by arterial blood gas tensions.
In a small single blind study Goroszeniuk et al'9 found fentanyl and diazepam given intravenously superior to premedication with papaveretum. For gastrointestinal endoscopy diazepam has been found superior to morphine20 and as good as the neuroleptanalgesic combination of phenoperidine and droperidol, which was found to produce a rise in end tidal carbon dioxide tension21 Opiates have the advantage that adverse effects can be rapidly reversed by naloxone and most bronchoscopists using opiates have this readily available. Neuroleptanalgesia is said to produce good recovery and the patient remains cooperative. The short acting opiates used are, however, potent respiratory depressants and droperidol may prevent the patient from showing distress because of the catatonia like state it may produce.22
The necessity for any sedation for fibreoptic bronchoscopy has been questioned23 and indeed 13 bronchoscopists in this study did not use sedation routinely.
The choice of sedative drugs and drug combinations is wide. It is illogical on pharmacological grounds to combine different opiates or benzodiazepines. 24 Regimens based on such combinations and those using three or more sedative drugs seem unnecessarily complex. In view of the morbidity associated with respiratory depression due to oversedation and the conflicting evidence about the most appropriate sedatives for this procedure using as simple a regimen as possible seems sensible.
Routine use of anticholinergic drugs is generally recommended to dry secretions and to prevent bradycardia'5 1625 26 and there is little variation in their use. The use of local anaesthesia is more contentious. Standard pharmacological sources27 28 give 200 mg as the maximum safe dose of lignocaine (though Martindale gives 600 mg for topical use29). Broncho-scopists generally recommend a maximum of 300 mg.2 7 16 25 30 Several studies have, however, shown that toxic blood concentrations are rarely reached during fibreoptic bronchoscopy even when this dose is exceeded.3 33 The dose of lignocaine used by respondents in this survey was often over 300 mg but only two serious reactions to lignocaine were reported. It seems likely that the recommendations are overcautious as much of the local anaesthetic solution is reaspirated through the bronchoscope and is thus not absorbed. Most bronchoscopists apply local anaesthetic in the traditional manner and recently described techniques using a fine tube or nebuliser are not widely used. Cricothyroid puncture is used by 15% of operators, although patients may find it unpleasant and it is not without risk. 37 and, for transbronchial biopsy, a preoperative clotting screen15 16 26 and use of fluoroscopy.1626 37 38 There is relatively little in the way of published evidence to support many of these recommendations.
Most bronchoscopists have their patients fasting for four or more hours, but surprisingly few give oxygen routinely despite the known deleterious effects of fibreoptic bronchoscopy on arterial blood gas tensions (the arterial oxygen tension often falling by 2 kPa or more)35 36 and an appeciable minority never use oxygen. There was, however, no significant relationship between reported complications and whether or not oxygen was administered routinely.
The availability of equipment for resuscitation and control of bleeding varied and the proportion of operators performing this invasive procedure without immediate access to cardiac resuscitation equipment was surprising.
Pneumothorax and haemorrhage are the major complications of transbronchial lung biopsy. It has been suggested that use of radiological screening is associated with a lower incidence of pneumothorax38 and this is supported by the present findings. There is no published evidence that clotting abnormalities contribute to bleeding after transbronchial biopsy but it would seem prudent to exclude them. Twenty five per cent of operators performed this procedure without a routine clotting screen before operation. The recommendations that transbronchial lung biopsy should be performed under radiological control and preceded by a clotting screen seem sensible.
Fibreoptic bronchoscopy is generally well tolerated, easy to perform and safe. It is important, however that the ease of performance and rarity of complications should not hide the fact that deaths and life threatening complications do occur. Physicians should exercise caution in selection of patients for bronchoscopy and, in view of the widely varying practice shown by the survey, review their use of sedative drugs and the availability of emergency equipment to try to minimise the risks.
